HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Y. John Gu Ad J.J.C. Bogers Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schreurs, H. H. Articles by Bogers, A. J.J.C. Search for Related Content PubMed PubMed Citation Articles by Schreurs, H. H. Articles by Bogers, A. J.J.C.

Ann Thorac Surg 1998;66:166-171
© 1998 The Society of Thoracic Surgeons

---

Original articles: cardiovascular

Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations

^a Thoraxcentre, University Hospital Rotterdam, Rotterdam, the Netherlands
^b Blood Interaction Research, University Hospital Groningen, Groningen, the Netherlands

Accepted for publication February 10, 1998.

Address reprint requests to Mrs Schreurs, Thoraxcentre, University Hospital Rotterdam, Bd 467, Dr Molewaterplein 40, 3015 GD Rotterdam, the Netherlands

Background. This study was designed to investigate whether clinical signs of the inflammatory response in pediatric cardiac patients are reduced by heparin-coated cardiopulmonary bypass circuits and how this could be explained by differences in the pathophysiologic mechanisms involved.

Methods. In a randomized, prospective study 19 patients underwent cardiopulmonary bypass either with Carmeda BioActive Surface bypass circuits (n = 9) or with identical noncoated circuits (control, n = 10). Clinical parameters were recorded during the first 48 hours after the start of operation. Blood samples for determination of terminal complement complex, soluble form of E-selectin, and beta-thromboglobulin were obtained perioperatively up to 24 hours after operation.

Results. All clinical and inflammatory mediators showed a tendency in favor of the group with heparin-coated circuits. When analyzed on a point-by-point basis there were significant differences in postoperative central body temperature, soluble E-selectin levels, and beta-thromboglobulin levels (all p < 0.05).

Conclusions. These data suggest that the use of heparin-coated cardiopulmonary bypass offers clinical benefit and tends to reduce the release of inflammatory mediators.

This article has been cited by other articles:

				O. Mangoush, S. Purkayastha, S. Haj-Yahia, J. Kinross, M. Hayward, F. Bartolozzi, A. Darzi, and T. Athanasiou Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes Eur. J. Cardiothorac. Surg., June 1, 2007; 31(6): 1058 - 1069. [Abstract] [Full Text] [PDF]

				E. Jensen, S. Andreasson, A. Bengtsson, H. Berggren, R. Ekroth, L. Lindholm, and J. Ouchterlony Influence of two different perfusion systems on inflammatory response in pediatric heart surgery Ann. Thorac. Surg., March 1, 2003; 75(3): 919 - 925. [Abstract] [Full Text] [PDF]

				E. R. Stephenson Jr and J. L. Myers Pediatric cardiopulmonary bypass Ann. Thorac. Surg., December 1, 2001; 72(6): 2176 - 2177. [Full Text] [PDF]

				H. A. Hennein Inflammation After Cardiopulmonary Bypass: Therapy for the Postpump Syndrome Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2001; 5(3): 236 - 255. [Abstract] [PDF]

				F. De Somer, K. Francois, W. van Oeveren, J. Poelaert, D. De Wolf, T. Ebels, and G. Van Nooten Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface Eur. J. Cardiothorac. Surg., November 1, 2000; 18(5): 602 - 606. [Abstract] [Full Text] [PDF]

				E. A. Grossi, K. Kallenbach, S. Chau, C. C. Derivaux, M. G. Aguinaga, B. M. Steinberg, D. Kim, S. Iyer, M. Tayyarah, M. Artman, et al. Impact of heparin bonding on pediatric cardiopulmonary bypass: a prospective randomized study Ann. Thorac. Surg., July 1, 2000; 70(1): 191 - 196. [Abstract] [Full Text] [PDF]

				E. A. Grossi, C. Derivaux, and A. LaPietra Heparin coating of bypass systems Ann. Thorac. Surg., July 1, 2000; 70(1): 335 - 335. [Full Text] [PDF]

				D. F Larson, D. Arzouman, L. Kleinert, V. Patula, and S. Williams Comparison of Sarns 3M heparin bonded to Duraflo II and control circuits in a porcine model: macro- and microanalysis of thrombi accumulation in circuit arterial filters Perfusion, January 1, 2000; 15(1): 13 - 20. [Abstract] [PDF]

				S. B. Horton, W. W. Butt, R. J. Mullaly, C. A. Thuys, E. B. O’Connor, K. Byron, A. D. Cochrane, C. P. Brizard, and T. R. Karl IL-6 and IL-8 levels after cardiopulmonary bypass are not affected by surface coating Ann. Thorac. Surg., November 1, 1999; 68(5): 1751 - 1755. [Abstract] [Full Text] [PDF]

				H. P Wendel, A. M Scheule, F. S Eckstein, and G. Ziemer Haemocompatibility of paediatric membrane oxygenators with heparin-coated surfaces Perfusion, January 1, 1999; 14(1): 21 - 28. [Abstract] [PDF]